U.K.’s Midatech Develops Transbuccal Insulin Using Gold Nanoparticles
This article was originally published in The Pink Sheet Daily
Executive Summary
The biocompatible gold nanoparticle technology being developed by the U.K. biotech can be used to carry insulin quickly to its site of action, and is also being evaluated with GLP-1 agonists and oncologics.